Overview

Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
0
Participant gender:
Female
Summary
In this study the investigators compare the traditional way of triggering with a new way in patients with Poly Cystic Ovary Syndrome (PCOS). This to reduce the risque of Ovary Hyper Stimulation Syndrome (OHSS) in In Vitro Fertilization/ IntraCytoplastic Sperm Injection (IVF/ ICSI) treatment. The investigators also compare the number of mature oocytes, embryo's and pregnancy rate.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
AZ Jan Palfijn Gent
Collaborator:
Onze Lieve Vrouw Hospital
Treatments:
Deslorelin
Triptorelin Pamoate
Criteria
Inclusion Criteria:

- ICSI patients below 38 years

- 1, 2 and 3e IVF cycle

- Body Mass Index (BMI) less than 32

- PCOS patients

Exclusion Criteria:

- endocrinal diseases or problems